News and Updates

  • Press release
  • News
29 Mar 2021

Coloplast awarded Ostomy Products contract with Vizient

Coloplast, a global medical device company and market leader in intimate healthcare, has been awarded a contract for ostomy products with Vizient, Inc., the largest health care performance improvement company in the US.

Read more

“I am excited about the agreement with Vizient and the potential it holds for our company, for Vizient members and for the many people living with an ostomy in the US. This agreement will strengthen our presence across hospitals and other healthcare organizations and enable us to provide our products and services to more and more users in the US,” says President & CEO of Coloplast, Kristian Villumsen.

The new agreement allows Vizient members access with contracted pricing to Coloplast’s full portfolio of ostomy products, including ostomy pouches and supporting products.

“We are delighted that Vizient has added us to their Ostomy Products portfolio. Vizient helps their members deliver high-value care to improve patient outcomes, and as a global market leader in intimate healthcare, we look forward to supporting that mission,” says Senior Vice President Manu Varma, Chronic Care North America.

The agreement is effective beginning July 1, 2021. As part of the contract, SenSura® Mio Baby & Kids, products developed by Coloplast for neonates, children and teenagers, will be included in Vizient’s Preferred Pediatric Program.

Vizient serves more than half of healthcare organizations across the country – from large integrated delivery networks and academic medical centers to community hospitals, children’s hospitals and non-acute care providers.

About Coloplast ostomy care products

Coloplast’s range of innovative ostomy products are designed to reduce leakage and maintain healthy skin. With the SenSura® Mio portfolio and BodyFit Technology, Coloplast has taken fit, flexibility, and comfort to a new level, creating a portfolio of innovative ostomy solutions that reduce the burden of leakage and enable users to live the life they want to lead.

In addition to product solutions, Coloplast has developed Coloplast® Care, the only manufacturer-provided patient support program with better patient outcomes supported by peer-reviewed data. Coloplast Care provides ostomy users access to product and lifestyle education and tools for self-assessment and individualized support from Care Advisors. Coloplast Care provides reliable information so ostomy users can better manage their care and experience a full life.

About Coloplast

Danish medical device company, Coloplast, develops products and services designed to make life easier for people with intimate health conditions. Coloplast listens to end-users to better understand their needs and responds by bringing the best ideas to market in the form of medical devices and service solutions.

Learn more on www.coloplast.us/about-us/our-company

Global press contact 
Peter Mønster, Senior Media Relations Manager
+45 4911 2623
dkpete@coloplast.com

Ellen Bjurgert, Vice President, Investor Relations
+45 4911 3376
dkebj@coloplast.com

 

  • Press release
  • News
16 Feb 2021

Coloplast celebrates 10th anniversary of its support of the American College of Surgeons Ostomy Home Skills kits

2021 marks 10 years of Coloplast’s support of the Ostomy Home Skills kits by the American College of Surgeons (ACS). These kits provide patients with comprehensive, interactive materials to enable learning and practicing of the skills needed for optimal postoperative recovery.

Read more

Patients that use the kit have more confidence in managing their ostomy than patients who do not use the kit. Further, those patients also use 42% fewer additional services1 and seek 50% less emergency room care2, compared with those not using the kits. We applaud the American College of Surgeons for leading this national quality initiative to improve education and outcomes for the ostomy patient. Associations who have collaborated in reviewing the skills kit content include:

  • American Society of Colon and Rectal Surgeons (ASCRS)
  • American Urological Association (AUA)
  • Wound Ostomy and Continence Nurses Society (WOCN)
  • United Ostomy Association of American (UOAA)
  • American Pediatric Surgical Association (APSA)
  • American Pediatric Surgical Nurses Association (APSNA)
  • ACS Commission on Cancer (CoC)

“Proper pre-surgical education is so vital for a patient facing a life-altering and often life-saving ostomy surgery. We have recently agreed to continue this support and are so proud to have supported thousands of patients using these kits over the last 10 years. We are committed to this type of education which has been proven to help reduce unnecessary healthcare utilization and improve outcomes,” says Vice President of Marketing Steen Morvan, Chronic Care in North America.

For more information on the ACS Ostomy Home Skills Kits visit https://www.facs.org/Education/Patient-Education/Skills-Programs/Ostomy-Program or to inquire with Coloplast about utilizing the kits in your pre-surgical pathway visit coloplast.to/teachingkit.

Coloplast is committed to improving outcomes via quality products and patient lifestyle support

Ostomy care is the 2nd leading cause of 30-day readmission rates3 in the United States. In addition to product solutions, Coloplast has developed Coloplast® Care, the only manufacturer-provided patient support program with better patient outcomes supported by peer-reviewed published data4. Coloplast Care provides ostomy product users access to education and tools for self-assessment and individualized support from Care Advisors. Coloplast Care provides reliable information so ostomy product users can better manage their care and experience a full life. For more information visit ostomy.coloplastcare.us

About Coloplast ostomy care products

Coloplast's range of innovative ostomy products are designed to reduce leakage and maintain healthy skin. With the SenSura® Mio portfolio and BodyFit Technology Coloplast has taken fit, flexibility, and comfort to a new level, creating a portfolio of innovative ostomy solutions that reduce the burden of leakage and enable product users to live the life they want to lead.

About Coloplast

Danish medical device company Coloplast develops products and services designed to make life easier for people with intimate health conditions. Coloplast listens to product users to better understand their needs and responds by bringing the best ideas to market in the form of medical devices and service solutions. www.coloplast.us/about-us/our-company/

About the American College of Surgeons/American College of Surgeons Foundation

The American College of Surgeons is a scientific and educational organization of surgeons that was founded in 1913 to raise the standards of surgical practice and to improve the care of the surgical patient. The College is dedicated to the ethical and competent practice of surgery. Its achievements have significantly influenced the course of scientific surgery in America and have established it as an important advocate for all surgical patients. The College has more than 82,000 members and is the largest organization of surgeons in the world. The American College of Surgeons Foundation was established in 2005 to provide philanthropic support for the research, education and patient safety programs of the American College of Surgeons.

Contact
Lina Danstrup
Senior Media Relations Manager, Corporate Communications
+45 4911 2607
dklina@coloplast.com

 

1, 2 Heneghan KC, McGee MF, Bailey HR, Sachdeva AK, Daly JM, Davis E, Colwell JC. Ostomy Home Skills Kit (OSHK) Is Effective at Preparing Patients to Confidently Manage Their Postoperative Recovery. Journal of Cancer Education. 2015;30(3):S320-21.

3 Audrey J. Weiss, Ph.D., et. Al. Readmissions to US Hospitals by Procedure. Statistical Brief #154, Healthcare Cost and Utilization project, Agency for healthcare research and quality, April 2013.

4 Results from a study comparing hospital readmission and emergency room (ER) visit rates attributable to ostomy complications between Coloplast Care program enrollees and non-enrollees (n=718). Published: Rojanasarot, S. The Impact of a Readily Available, Post-Discharge Support Program for Ostomy Surgery Patients on Preventable Health Care Utilization, Journal of Wound Ostomy & Continence Nursing. 2018;45(1):43-49.

  • Press release
  • News
29 Sep 2020

Coloplast completes minority investment in Francis Medical

Coloplast announced today that it has completed a USD 4m (DKK 25m) equity investment in Francis Medical, an early stage company pioneering urological cancer treatments, beginning with prostate cancer.

Read more

Founded in 2018, Minneapolis-based Francis Medical is a privately held company committed to developing minimally invasive urological cancer treatments. The foundation of the company is a tribute to and legacy of the inventor’s father, Francis Hoey, whose life was ended by prostate cancer with treatments that had harsh implications on his normal daily living.

The platform technology utilizes water vapor energy to ablate targeted cancerous tissue while preserving surrounding structures, potentially minimizing the side effects often experienced with other cancer treatments.

The investment fits with Coloplast’s strategy to pursue organic and inorganic growth opportunities in the Interventional Urology business. Francis Medical in particular and the prostate cancer segment in general align with the Interventional Urology’s strategic direction, bringing innovative solutions to the urology market.

“We are proud to be supporting life-changing technologies in growing urology segments. As part of our long-term strategy we are exploring multiple areas for investment and growth, and we are excited about providing solutions in Men’s Health segments like prostate cancer,” said Steve Blum, President of Interventional Urology.

Coloplast is dedicated to making life easier for people with intimate healthcare needs and advancing the treatment of prostate cancer supports that mission. The investment in Francis Medical will help the company continue to develop their minimally invasive solution and help Coloplast Interventional Urology continue to grow its presence in the market with customers and patients.

“There is a large unmet need for patients seeking treatment alternatives with fewer side effects than radiation or a radical prostatectomy. We are working to address that unmet need and are excited to have the support of a leader in urology like Coloplast to improve the treatment of prostate cancer,” said Mike Kujak, CEO of Francis Medical.

For more information on Francis Medical please refer to www.francismedical.com.

About Coloplast

Danish medical device company Coloplast develops products and services designed to make life easier for people with intimate health conditions. Coloplast listens to end-users to better understand their needs and responds by bringing the best ideas to market in the form of medical devices and service solutions. Learn more on www.coloplast.us/about-us/our-company/

Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate healthcare. Our business includes Ostomy Care, Continence Care, Wound and Skin Care and Interventional Urology. We operate globally and employ about 12,000 employees.

Global press contact 
Lina Danstrup, Senior Media Relations Manager
+45 4911 2607
dklina@coloplast.com

Ellen Bjurgert, Vice President, Investor Relations
+45 49 11 33 76
dkebj@coloplast.com

 

  • Press release
  • News
25 Jun 2020

Coloplast US Named a 2020 Top Workplace

The company receives recognition for strong values and company culture.

Read more

Coloplast US announced today that it is included among the Star Tribune’s Top 150 Workplaces in Minnesota. This is the first year the company has made the list, receiving recognition for its commitment to company culture, specifically around trust in leadership, well-informed employees, and strong company values. The company ranked #36 on the list.

 

The Star Tribune 150 recognizes the most progressive companies in Minnesota based on employee opinions measuring engagement, organizational health and satisfaction.The analysis included responses from more than 76,000 employees at nearly 3,000 Minnesota public, private and nonprofit organizations. Rankings were composite scores calculated purely on the basis of employee responses.

 

“Our employees are passionate about carrying out our mission of helping people with intimate healthcare needs, so they are able to live their lives with confidence. This recognition helps distinguish Coloplast as an employer of choice for people looking to advance their careers at a fast-growing, closely-knit company that prioritizes trust, collaboration, and open communication,” said Manu Varma, president and SVP of Chronic Care North America.

 

Star Tribune Publisher Michael J. Klingensmith said, “The companies in the Star Tribune Top 150 Workplaces deserve high praise for creating the very best work environments in the state of Minnesota. My congratulations to each of these exceptional companies.”

 

Coloplast is a medical device company that develops products and services designed to make life easier for people with intimate health conditions. Coloplast listens to its users to better understand their needs and responds by bringing the best ideas to market in the form of medical devices and service solutions.

 

Coloplast is growing and hiring for many positions. To see current job openings and learn how to join the Coloplast team, visit the company’s Careers page.

 

CONTACTS 
Lina Danstrup

Senior Media Relations Manager, Corporate Communications

+45 4911 2607

dklina@coloplast.com

 

  • Press release
  • News
7 Jan 2020

Coloplast awarded Enterostomal Therapy products agreement with Premier Inc.

Coloplast, a global medical device company and market leader in intimate healthcare needs, has been awarded a three-year group purchasing agreement for ostomy products with Premier Inc. in the US.

Read more

The new agreement allows Premier members access to Coloplast's full portfolio of ostomy products, including ostomy pouches and supporting products.

 

"We are delighted that Premier has added us to their Enterostomal Therapy contract. Coloplast shares Premier's core values to improve patient outcomes and provide value to its customers, and we look forward to doing exactly that for Premier's membership," says Senior Vice President Manu Varma, Chronic Care North America.

 

The agreement is multi-source and effective for three years beginning April 1, 2020. Premier is a leading healthcare improvement company, uniting an alliance of approximately 4,000 U.S. hospitals and hospital systems and more than 175,000 other providers to transform healthcare.

 

About Coloplast ostomy care products

Coloplast's range of innovative ostomy products are designed to reduce leakage and maintain healthy skin. With the SenSura® Mio portfolio and BodyFit® Technology Coloplast has taken fit, flexibility, and comfort to a new level, creating a portfolio of innovative ostomy solutions that reduce the burden of leakage and enable users to live the life they want to lead.

 

In addition to product solutions, Coloplast has developed Coloplast® Care, the only patient support program option with better patient outcomes. Coloplast Care provides ostomy users access to education and tools for self-assessment and individualized support from Care Advisors. Coloplast Care provides reliable information so ostomy users can better manage their care and experience a full life.

 

About Coloplast

Danish medical device company Coloplast develops products and services designed to make life easier for people with intimate health conditions. Coloplast listens to end-users to better understand their needs and responds by bringing the best ideas to market in the form of medical devices and service solutions.

 

Learn more on www.coloplast.us/about-us/our-company

 

 

CONTACTS 
Lina Danstrup

Senior Media Relations Manager, Corporate Communications

+45 49 11 26 07

dklina@coloplast.com

 

Ellen Bjurgert

Vice President, Investor Relations

+45 49 11 33 76

dkebj@coloplast.com 


  • Press release
  • News
9 Jul 2019

Coloplast completes its SenSura® Mio ostomy care range with new innovative products for premature babies and kids

Coloplast proudly presents two new members of the SenSura® Mio family, SenSura® Mio Baby and SenSura® Mio Kids. The new products are designed specifically for premature babies and kids. As part of the launch, Coloplast is also publishing best practice guidelines created by stoma care nurses with solid experience treating babies and kids living with a stoma.

Read more

Our bodies are different, and it is a challenge to create products to fit individual bodies. This is also the case when it comes to premature babies and kids. That is why Coloplast is proud to present two additional and customised SenSura® Mio ostomy care products, SenSura® Mio Baby and SenSura® Mio Kids. Coloplast now offers a full range of ostomy care products to fit everyone and every body profile.


While SenSura® Mio, SenSura® Mio Convex, and SenSura® Mio Concave are designed to fit the individual shapes of adults with regular, inward, and outward body profiles, SenSura® Mio Baby and SenSura® Mio Kids are designed and developed especially for babies and kids.

 

“While it is uncommon for babies and kids to undergo stoma surgery, we want to make sure those who do have the best possible products. Despite it being difficult to create a great fit for the littlest of users, our latest products do just that,” says CEO Kristian Villumsen, Coloplast.

 

"As a market leader, we are proud to offer innovative products like SenSura® Mio Baby and SenSura® Mio Kids, which helps these little ostomates live healthy lives and not be limited by their conditions,” says Mr. Villumsen.

 

New best practice guidelines by stoma care professionals

The SenSura® Mio Baby products aim to provide longer wear time, as especially premature babies have sensitive skin, which needs as much peace and quiet as possible.

 

The new products include a best practice guideline developed by pediatric stoma care nurses with solid experience with babies and kids living with a stoma.

 

Red Dot award winner

Both SenSura® Mio Baby and SenSura® Mio Kids have won the Red Dot Award: Product Design 2019. The 'Red Dot' is the award for high quality design, and the international jury grants this seal of quality to products that feature an innovative and outstanding design.

 

“With the star-shaped baseplate, SenSura® Mio Kids is designed specifically for children’s round bellies. It is exciting to see the innovative SenSura® Mio Baby and SenSura® Mio Kids products being recognised for its design. I believe that these products successfully combine functionality and design – this is design with a purpose,” says SVP of Global Marketing Rasmus Hannemann, Coloplast.

 

Learn more on: www.red-dot.org

 

 

  • SenSura® Mio Baby and SenSura® Mio Kids will be launched in Coloplast’s key markets throughout 2019.
  • Coloplast is the global market leader in ostomy care products, holding 35-40% of the market.
  • Photos of SenSura® Mio Baby and SenSura® Mio Kids are available on https://www.coloplast.com/press/download-images/

 

 

CONTACTS 
Lina Danstrup

Senior Media Relations Manager, Corporate Communications

+45 49 11 26 07

dklina@coloplast.com

 

Ellen Bjurgert

Vice President, Investor Relations

+45 49 11 33 76

dkebj@coloplast.com 


  • Press release
  • News
25 Feb 2019

Coloplast awarded general urological products agreement with Premier Inc.

Minneapolis (February 25, 2019) - Coloplast, a global medical device company and leader in intimate healthcare needs, has been awarded a three-year group purchasing agreement for general urological products with Premier. The new agreement allows Premier members access to Coloplast’s full portfolio of general urological products, including catheters, drainage systems and accessories.

Read more

Coloplast awarded general urological products agreement with Premier Inc.

 

Coloplast, a global medical device company and leader in intimate healthcare needs, has been awarded a three-year group purchasing agreement for general urological products with Premier. The new agreement allows Premier members access to Coloplast’s full portfolio of general urological products, including catheters, drainage systems and accessories.

 

“We are extremely honored that Premier Inc. has chosen to work with Coloplast. Coloplast shares Premier’s core values to improve patient outcomes and provide value to its customers,” said Manu Varma, senior vice president of Chronic Care North America.

 

The agreement is effective for three years beginning March 1, 2019. Premier is a leading healthcare improvement company, uniting an alliance of approximately 4,000 U.S. hospitals and 165,000 other providers to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and advisory and other services, Premier enables better care and outcomes at a lower cost.

 

About Coloplast continence care products

Coloplast’s range of innovative continence care products are created to allow users to better control their bladder management. By working closely with clinical experts and patients who use catheters daily, we have developed award-winning products. This includes SpeediCath®, the world’s first ready-to-use hydrophilic-coated intermittent catheter, and Conveen® Optima, the next generation of male external catheters. These products are designed to improve the quality of life for those in need and are preferred by users.

 

In addition to product solutions, Coloplast has developed Coloplast® Care, a patient support program which provides catheter users access to education and tools for self-assessment and individualized live support from Care Advisors. Coloplast Care provides reliable information so catheter users can better manage their care and experience a full life.

 

About Coloplast

Danish medical device company Coloplast develops products and services designed to make life easier for people with intimate health conditions. Coloplast listens to end-users to better understand their needs and responds by bringing the best ideas to market in the form of medical devices and service solutions. www.coloplast.us/about-coloplast

 

Global press contact

Lina Danstrup, Senior Media Relations Manager

+45 4911 2607

dklina@coloplast.com  

  • Press release
  • News
12 Feb 2019

Coloplast continues to expand its SenSura® Mio ostomy range with the new, innovative, first-of-its-kind SenSura® Mio Convex Flip ostomy product.

Minneapolis (February 12, 2019) - Coloplast, a global medical device company and leader in intimate healthcare needs, continues to expand its SenSura® Mio ostomy range with the new, innovative, first-of-its-kind SenSura® Mio Convex Flip ostomy product.

Read more

Coloplast continues to expand its SenSura® Mio ostomy range with the new, innovative, first-of-its-kind SenSura® Mio Convex Flip ostomy product.

 

Designed specifically for the outward body shapes – and the first of its kind in the ostomy market – the new SenSura® Mio Convex Flip is now available in the United States.

 

All bodies are different, and it is a challenge to create products to fit individual bodies. The SenSura Mio ostomy care portfolio is intended to meet the differing needs of ostomates through its BodyFit Technology®. Flat and convex barriers are common, which the SenSura Mio offers a solution for.

 

SenSura Mio Convex Flip is a new solution for people with an outward body profile and is the first ostomy appliance designed specifically for those that are overweight, obese, or have parastomal bulges or hernias.

 

“With the addition of SenSura® Mio Convex Flip, we continue to build out our ostomy SenSura® Mio portfolio to meet more people’s needs. It is difficult to make a great fit for people with outward body profiles, but the curved, star-shaped barrier can do just that. We are confident that this will make a big difference to our users and give Coloplast a strong competitive edge,” says CEO Kristian Villumsen, Coloplast.

 

Committed to improving outcomes via quality products and life-long patient support

Ostomy care is the 2nd leading cause of 30-day readmission rates in the United States. Coloplast® Care, a comprehensive patient support program, provides patients with individualized support, education, and tools via a patient-focused advisor. The program has been shown to reduce 30-day readmission rates by 30 percent and ER visits by 45 percent.

 

“SenSura® Mio Convex Flip provides a new option for those living with an ostomy. By offering a new innovative product that supports the needs of more users, combined with the Coloplast Care program, we not only impact the quality of life for people living with a stoma – we also make a positive effect on health outcomes,” says Senior Vice President Manu Varma, Chronic Care in North America.

 

Coloplast is the global market leader in ostomy care products, holding 35-40% of the market. Ostomy care products experienced 9% organic growth in 2018, with double-digit growth coming from the United States.

 

Contacts

Lina Danstrup

Senior Media Relations Manager, Corporate Communications

+45 4911 2607

dklina@coloplast.com

Close

Order your free samples

Thank you for your order

Your order is complete!

View desktop version